KRAS and ovarian serous carcinoma: We reported earlier that KRAS or BRAF mutations were quite common in low-grade serous ovarian carcinomas with prototypic histology of type I ovarian carcinoma but rare in high-grade serous ovarian carcinomas [8,10].